Vanguard Portfolio Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Vanguard Portfolio Management's AMRX Position: Q3 2026 in Review
Vanguard Portfolio Management increased its Amneal Pharmaceuticals (AMRX) stake by 1.9% in Q3 2026, buying an estimated $4.11M and bringing the position to 12,365,663 shares worth $249M. The position accounts for 0.01% of the portfolio, ranked #1049.
Vanguard Portfolio Management first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Vanguard Portfolio Management held 12,365,663 shares of Amneal Pharmaceuticals worth $249M as of Q3 2026.
- Vanguard Portfolio Management bought 227,936 Amneal Pharmaceuticals shares in Q3 2026, an estimated $4.11M.
- Amneal Pharmaceuticals made up 0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1049 holding.
- Vanguard Portfolio Management first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.